In any industry, M&A is challenging. In cannabis, the issues can be even more complex. This deeper dive panel will focus on five of the most difficult legal issues to manage in these transactions. They include: non-competes/non-solicitations, earn-out provisions, implications of cash vs. stock components in consideration, consideration dependent on future legalization efforts, and clarifying state approval processes for transactions. Join this panel to hear more about these challenging issues and the best strategies for addressing them in individual transactions.
This program is eligible for 1.25 hours of General CLE credit in 60-minute states, and 1.4 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|Cannabis M&A CLE materials 6.4.2022 (38.3 KB)||Available after Purchase|
|M&A-Cannabis.220524.02 (298 KB)||Available after Purchase|
David N. Feldman concentrates his law practice on corporate and securities law and mergers and acquisitions, as well as general representation of public and private companies, entrepreneurs, investors, and private equity and venture capital firms. David has represented a wide range of clients in the legal cannabis and psychedelics industries since 2013. He provides guidance on private placements, public offerings, loan structuring and fund formation for cannabis companies, as well as corporate structuring advice and applications for grow, processing and dispensary licenses. He also advises on risk assessment issues for large, multinational businesses seeking to enter the cannabis industry. The global guide Chambers & Partners ranked Mr. Feldman as a leading US attorney in cannabis law and one of only seven US lawyers in “band 1” for corporate and transactional work in the industry. In addition, the National Law Journal named him a “Cannabis Law Trailblazer” and Business Insider named him as a top lawyer in the cannabis industry. He has also been listed several times in the Top 200 Cannabis Lawyers published by Cannabis Law Digest. David is the former team lead of an AmLaw 100 firm’s 60-attorney Cannabis Industry Group. He frequently speaks at industry conferences and is quoted by numerous publications about legal developments and business and finance news in this rapidly expanding market. In addition to serving as Managing Partner of Feldman Legal Advisors PLLC, he is co-founder and CEO of Skip Intro Advisors, LLC, a cannabis and psychedelics-focused business consutling firm focused on strategic guidance, finance and M&A and regulatory advice. In a recent win, last year he served as M&A advisor and also counsel to Keystone Canna Remedies, a three-dispensary group in Pennsylvania, in their sale to TerrAscend at a $70 million enterprise value.
David also advises emerging growth companies in a range of industries with regard to alternatives to traditional financing through initial public offerings, and is considered an authority on public offerings through SEC Regulation A+. He published a book on that subject, called Regulation A+ and Other Alternatives to a Traditional IPO (John Wiley & Sons), in 2018. David has also published The Entrepreneur’s Growth Startup Handbook: 7 Secrets to Venture Funding and Growth Success (2013) and the award-winning Reverse Mergers and Other Alternatives to a Traditional IPO (First Edition 2006, Second Edition 2009). A Wharton School and University of Pennsylvania Law School graduate and former Chair of Wharton’s worldwide alumni, David is not just a lawyer – he’s a community builder. He’s run, built, bought, invested in, and sold businesses. He feels his clients’ pain but provides the objective outsider’s point of view that founders need.
Samantha Gleit is a partner at Feuerstein Kulick, focusing on debt and equity financing, corporate restructuring, alternative capital sources, acquisition financing, senior and mezzanine investments, and related commercial transactions. In 2021, Samantha was selected by Law360 as a “Rising Star” in the cannabis industry for top attorneys under 40 whose legal accomplishments transcend their age.
Throughout her career, Samantha has advised institutional and alternative investors on distressed debt and high risk lending. She is known for implementing tailored, regulatory-compliant, loan and workout structures designed to maximize protection in the evolving cannabis legal landscape. Samantha also has extensive experience advising companies (ranging from startups to large public companies) on debt structure, risk management, workouts, acquisition financing, capitalization and compliance. Beyond traditional legal advice, Samantha also assists startups and growing companies identify liquidity sources, develop growth strategies and negotiate efficient financing solutions.
Recent representations include GlassHouse; Jushi; Holistic; Loudpack; lenders to Curaleaf, Terrascend, and Cresco; cannabis-focused REITs, a private lender in a $250 million senior secured credit facility with the factoring arm of a wholesale B2B marketplace; Navy Capital in leading in a private placement of convertible debt with 4Front; and FocusGrowth Capital Partners on debt and equity financings with various multi-state and single state operators.
Samantha is regularly interviewed and published in leading debt media outlets. In addition to being selected as a top cannabis lawyer under 40 in 2021 by Law360, Samantha was selected as a Rising Star in the 2015 – 2021 editions of New York Metro Super Lawyers® and featured in The New York Times Magazine Super Lawyers® Top Women Attorneys in the New York Metro Area. Samantha is regularly interviewed by legal publications on debt and equity financing in the cannabis industry. She has also co-authored an article featured on the cover of the ABI Journal discussing suggested reforms to the federal bankruptcy process. In 2013, Samantha was awarded the International Bar Association’s Insolvency Scholarship for her award winning article on distressed law firms. Prior to joining Feuerstein Kulick, Samantha worked at King & Spalding LLP in New York, in the corporate finance and investments group.
Daniel Haymann heads MLL’s cannabis practice. He specializes in corporate and commercial law as well as on regulatory matters in the cannabis industry and advises investors, start-ups and vertically integrated companies along the value chain. Prior to embarking on a second career as an attorney, Daniel gained over 12 years of experience in the trading, mining, energy and related industries based out of Switzerland, Singapore and Hong Kong, working for multinational corporations as a trader and in managerial positions. He is a member of the Zurich and Swiss Bar Associations, the European Industrial Hemp Association (EIHA) and is the Co-Chair of the International Cannabis Bar Association (INCBA) Europe Chapter. Daniel regularly moderates panels and participates as a speaker in international cannabis conferences.
Please wait ...